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Female sex hormones have long been suspected to have an effect onmast cell (MC) behav-
ior.This assumption is based on the expression of hormone receptors in MCs as well as on
the fact that many MC-related pathophysiological alterations have a different prevalence in
females than in males. Further, serum IgE levels are much higher in allergic female mice
compared to male mice. Ovariectomized rats developed less airway inﬂammation com-
pared to shamcontrols. Following estrogen replacement ovariectomized rats re-established
airway inﬂammation levels’ found in intact females. In humans, a much higher asthma
prevalence was found in women at reproductive age as compared to men. Serum levels
of estradiol and progesterone have been directly correlated with the clinical and functional
features of asthma. Around 30–40% of women who have asthma experienced worsening
of their symptoms during the perimenstrual phase, the so-called perimenstrual asthma.
Postmenopausal women receiving hormone replacement therapy have an increased risk
of new onset of asthma. Beside, estrus cycle dependent changes on female sex hormones
are related to changes on MC number in mouse uterine tissue and estradiol and proges-
terone were shown to induce uterine MC maturation and degranulation. We will discuss
here the currently available information concerning the role of these female sex hormones
on MC behavior.
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INTRODUCTION
Mast cells (MCs) belong to the innate-compartment of the
immune system and are widely known for their role in allergic
reactions via their binding to IgE receptor (Alvarez-Errico et al.,
2009). MCs are a common cellular component of both con-
nective and mucosal tissues (Kitamura and Ito, 2005). Beside
this, MCs contain a wide range of biologically active molecules,
including biogenic amines, heparin or heparan sulfate proteo-
glycans, neutral proteases, and neuropeptides. In addition, upon
stimulation, they also produce and eject a large number of fac-
tors (Wilhelm et al., 2000). Taking these characteristics together,
it is clear that even a small number of such potent unicel-
lular glands have a signiﬁcant effect on different physiological
processes.
In addition to the very well known and described mecha-
nism of MC activation and posterior degranulation throughout
IgE receptor, several other alternative but not redundant mecha-
nisms of MC activation have been described (Mousli et al., 1994;
Bradding, 2005; Kim et al., 2008). Among others, female sex hor-
mones, estradiol and progesterone, have been proposed to activate
MC (Chancey et al., 2005; Vasiadi et al., 2006; Narita et al., 2007;
Zaitsu et al., 2007; Jensen et al., 2010; Jing et al., 2011; Walter
et al., 2011). We will discuss in this review the current bibliog-
raphy evidences about the effect of female sex hormones on MC
functionality.
MAST CELLS EXPRESS ESTRADIOL AND PROGESTERONE
RECEPTORS AND FURTHER RESPOND TO THESE HORMONES
Female sex steroid hormones act primarily via their recep-
tors: estrogen via estrogen receptor ERα or ERβ, progesterone
via progesterone receptor PR-A or PR-B (Carey et al., 2007).
Steroid receptors are best described as nuclear receptors acting
as transcription factors on gene expression. However, in the
past decade abundant evidences accumulated showing addition
binding sides localized at the plasma membrane (Levin, 2011),
whose activation is more often involved in the rapid effects of
steroids occurring within seconds to minutes (Watson et al., 1999;
Watson and Gametchu, 2003). In this regard, it has been shown
that classical ERα at themembrane but not in the nucleusmediates
17β-estradiol (E2)-induced rapid signaling to kinase activation
(Levin, 2011). Similarly, extra-nuclear PR induces activation of
ERK/MAPK kinases, which lead to cell surviving as well as cells
migration (Levin, 2011). We and other authors have demon-
strated the expression of, estradiol and progesterone receptors in
human, mouse, and rat MCs (Theoharides et al., 1993; Chancey
et al., 2005; Pang et al., 1995; Narita et al., 2007; Zaitsu et al.,
2007; Jensen et al., 2010; Jing et al., 2011). Zaitsu et al. (2007)
have shown mRNA expression of ERα but not ERβ in human
and mouse MCs. Alongside the authors have also shown that E2
rapidly stimulated MC degranulation which could be blocked by
tamoxifen, a tissue speciﬁc ER antagonist, clearly indicating that
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estradiol-induced MC degranulation throughout one of its recep-
tors. Bone marrow-derived MCs (BMMCs) isolated from ERα
knockout animals did not degranulate in response to E2 treatment
conﬁrming that the E2 effect on MCs is more likely mediated by
the ERα (Zaitsu et al., 2007). Due to the rapid onset of E2 effect
on MC activation the authors concluded that E2 in this context
does not function through the classical (genomic) mechanisms,
which require enhanced mRNA and protein synthesis over 2 h
or longer period and proposed that the effect is mediated by a
membrane-associated (non-genomic) form of ER (Zaitsu et al.,
2007). We were additionally able to show that the human mast cell
line (HMC-1) treated in vitro with physiological concentration
of E2 and P4 signiﬁcantly increased the synthesis of β-tryptase,
which is a serine proteinase abundantly produced by MCs, and
is a marker of MC maturation. Beside, E2 and P4 treatment
induced degranulation of HMC-1 in vitro (Jensen et al., 2010).
Supporting the idea of female sex hormones having an effect on
MC function, Kirmaz et al. (2004) have demonstrated that allergen
skin prick tests (SPT), a very sensitive and speciﬁc tests to detect
allergic sensitization in atopic patients, is altered in women upon
hormonal changes during the menstrual cycle.
In addition to female sex hormone receptor expression, MCs
have been also shown to express androgen receptor (Chen et al.,
2010). However, testosterone treatment had no effect on MC
degranulation (Chen et al., 2010).
INFLUENCE OF ESTRADIOL AND PROGESTERONE ON MC
FUNCTION: DO THESE HORMONES PLAY A ROLE IN
MC-RELATED DISEASES?
The idea that female sex hormones, E2 and P4, may affect MC
functionality and therefore have an inﬂuence on the symptoms
of MC-associated disorders has long been suggested. Asthma and
other allergic diseases of the airway are up to three times more
common in women than in men during the early to middle
adulthood and remains so through the reproductive years (De
Marco et al., 2002; Mannino et al., 2002; Schatz and Camargo,
2003). A number of clinical and epidemiological studies suggested
that female sex hormones are accountable for these differences.
Beside this, postmenopausal women taken hormone replace-
ment therapy had higher risk of new onset of asthma (Barr
et al., 2004). Furthermore, 30–40% of women who had asthma,
experience a worsening of their symptoms during the peri-
menstrual phase of the menstrual cycle (perimenstrual asthma)
being the time point when E2 and P4 concentrations are chang-
ing rapidly (Vrieze et al., 2003). In this context, it is of great
importance to mention that the prevalence and morbidity of
asthma and other allergic diseases have increased dramatically
during the last 30 years, particularly in developing countries
(Burr et al., 2006). Narita et al. (2007) have nicely demonstrated
that this may be related to the increase of low concentrations
of environmental like-estrogen compounds. These estrogen-like
compounds, called xenoestrogens, are present in the environmen-
tal pollutants mainly in water and food. They are able not only
to activate MCs but enhance MC degranulation upon allergen
cross-linking of IgE which may explain the above described incre-
ment of allergic diseases in the last years in developing countries
(Narita et al., 2007).
In an animal model of allergic disease, the role of female sex
hormone was tested. Female mice have reportedly an increased
susceptibility to allergic airway disease in compared with male
mice (reviewed in Carey et al., 2007). Levels of IgE are much
higher in allergic female mice compared to their syngeneic male
(Corteling and Triﬁlieff, 2004). Female rats that underwent
ovariectomization developed less airway inﬂammation compared
with sham controls animals (Ligeiro de Oliveira et al., 2004).
However, estrogen replacement in the ovariectomized animals re-
established airway inﬂammation levels of intact females (Ligeiro
de Oliveira et al., 2004). Treatment of intact female rats with
the selective estrogen receptor antagonist tamoxifen also reduced
the development of allergic airway disease (Ligeiro de Oliveira
et al., 2004). Thus, the direct effect of these hormones on disease
development is hereby demonstrated.
Beyond the well-documented effects of estradiol and pro-
gesterone on MC function in MC-associated diseases, these
hormones were further implicated in controlling different MC
process under physiological conditions. For instance, estradiol
was showed to be a potent inducer of ovarian MC degran-
ulation, which seems to be a necessary factor during the
process of oocyte ovulation (Jaiswal and Krishna, 1996; Tamura
and Kogo, 1999).
MC NUMBER, MATURATION, AND DEGRANULATION IN
THE UTERUS ARE UNDER THE CONTROL OF FEMALE
SEX HORMONES
The presence of MCs in the uterus has been already described
in many species including human (Drudy et al., 1991), mouse
(Padilla et al., 1990), rat (Aydin et al., 1998), hamster (Har-
vey, 1964) as well as goat (Karaca et al., 2008). Besides, the
number of MCs in the uterus was shown to ﬂuctuate dur-
ing estrous cycle suggesting an inﬂuence of female sex hor-
mones on MC recruitment to the uterus (Aydin et al., 1998).
Ovariectomized mice, in which estradiol and progesterone are
almost absent, have less number of uterine MCs compared to
control, non-ovariectomized animals (Jensen et al., 2010). Hor-
monal replacement, estradiol alone or in combination with
progesterone, restored the number of uterine MCs after ovariec-
tomization, which was comparable to the levels observed in
control mice (Jensen et al., 2010). Hormonal replacement addi-
tionally induced an augmentation in the levels of MC-related
proteases expression in the uterus as well as boosted MC degran-
ulation (Jensen et al., 2010). This is of particular importance
because upon degranulation, MCs release several molecules (his-
tamine, proteases, metalloproteinases, pro-angiogenic factors),
all very well known to account for the process of embryo
implantation.
CONCLUSION
Mast cells, the so-called unicellular glands, once solely known as
effectors cells of the innate immune system only activated by IgE
cross-linking to the IgE receptor upon allergen stimulation are
now known to be much more plastic and susceptible to be acti-
vated by several factors including female sex hormones, estradiol
and progesterone. Strong data in the last years reinforced the idea
that these hormones are crucial component of MC behavior not
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only in physiological conditions but also in several MC patholog-
ical situations. Deciphering the mechanisms by which female sex
hormones activate MCs and under which conditions these hap-
pens, alongside with explanation why female sex hormones have
these effects is of crucial interest for a better understanding of the
physiology of these cells.
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